actin binding comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-05-18. Numbers and descriptions here follow the published literature rather than marketing material.
TB-500 is a synthetic seven-residue peptide whose sequence, LKKTETQ, matches the N-terminal actin-binding region of thymosin beta-4. It is usually supplied in an N-terminally acetylated form, a modification that blocks the free amino terminus and can influence behavior in solution. In the research literature the same sequence appears under several names, including thymosin beta-4 fragment and shortened thymosin beta-4. Because it is a short peptide rather than the full 43-residue parent protein, its measured properties differ from those reported for thymosin beta-4 as a whole, and the two are not interchangeable in experimental design.
Thymosin beta-4 itself is a small, widely expressed protein that sequesters monomeric actin and participates in cell migration, angiogenesis, and tissue repair. Researchers have examined the shortened fragment as a possible mimic of some of these activities, reasoning that the actin-binding motif lies within the first few residues. Binding to monomeric actin has been observed in cell-free systems. Whether the fragment reproduces the broader effects of the full protein in living tissue remains an open question, and findings from animal models are frequently cited without a clear bridge to human physiology.
Discussion of TB-500 appears in several distinct literatures that rarely cite one another. Peer-reviewed studies usually describe in vitro assays or small animal experiments and are cautious about extrapolation. Veterinary and sports communities circulate anecdotal reports with limited methodological detail. Commercial listings add a third layer, often using the name interchangeably with thymosin beta-4 even though the two molecules differ in size and sequence. Regulatory status varies by country, and the compound is not a licensed medicine in most jurisdictions, so readers comparing sources should check which molecule and which purity each source actually describes.
Animal work has examined the peptide in models of cardiac injury, skin wounding, and corneal repair, with reported outcomes covering cell migration, inflammatory cell influx, and tissue remodeling. Several of those experiments used the full-length protein or longer fragments instead of the seven-residue sequence, which makes direct comparison between reports difficult. Results are generally described as tissue-dependent, and effect sizes vary considerably across laboratories. Independent replication is uneven, so the overall picture is incomplete rather than settled.
Controlled human trials of the short fragment are scarce. Much of what appears in review articles is extrapolated from animal models or from studies of the parent protein, and literature searches return a larger body of cardiac and ophthalmic work on thymosin beta-4 than on the abbreviated peptide. Regulatory treatment differs by jurisdiction, and in several countries the material is handled as a research chemical rather than an approved therapeutic. Statements about human benefit should be read as provisional.
Biological interest in this peptide centers on its relationship to actin dynamics. Thymosin beta-4 binds monomeric actin through an LKKTET motif, and a short sequence carrying that motif can compete with other actin-binding proteins in cell-free preparations. Investigators propose that such competition shifts the balance between filament assembly and disassembly, which in turn affects how readily a cell extends protrusions and migrates. Most of the supporting observations come from cultured cells and purified protein systems rather than from intact organisms.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | N-terminal fragment of thymosin beta-4 |
| Residue count | Seven | Sequence LKKTETQ |
| Approximate mass | 889 Da | Acetylated seven-residue peptide |
| Common synonyms | TB4 fragment, TB500 | Not identical to full-length TB4 |
| Reported activity | Actin binding | Observed mainly in cell-free systems |
The designation TB-500 circulates in laboratory and catalog contexts without a single agreed definition. Most product listings apply it to an N-terminally acetylated seven-residue fragment of thymosin beta-4, while other listings attach the same label to the full 43-residue protein. Because the term is commercial rather than systematic, two entries bearing identical names may describe different molecules. Any documentation should therefore state which sequence a given sample is claimed to contain.
The fragment most often associated with the name carries the sequence Ac-LKKTETQ, matching residues 17 through 23 of thymosin beta-4. That region holds the actin-binding motif responsible for much of the parent protein's biochemical activity. Apart from N-terminal acetylation the peptide is unmodified and contains no disulfide bonds, so it shows little ordered secondary structure in solution. Full-length thymosin beta-4 is instead a 43-residue polypeptide of roughly 4.9 kDa found widely across mammalian cell types.
Material sold under this label typically arrives as a freeze-dried powder in a sealed vial with a certificate of analysis. Such certificates usually report reversed-phase chromatography purity plus a mass confirmation, and stated purities commonly sit between 95 and 99 percent. Counter-ion identity, residual trifluoroacetate, water content, and peptide net weight are separate specifications that a certificate may or may not include. A purity figure alone does not establish sequence identity, so independent mass verification remains the practical check.
Lyophilized peptide arrives as a dry cake that should stay sealed until use. Reconstitution is generally performed with sterile water or a buffered solution, and the resulting liquid should be handled gently to limit mechanical stress. Repeated freeze-thaw cycles are widely described as harmful to short peptides, so dividing a reconstituted batch into single-use portions is a common practice. Laboratories also record the solvent, concentration, and date of preparation on the vial label to keep later measurements traceable.
Dry powder is commonly held at minus twenty degrees Celsius, with some suppliers recommending lower temperatures for long-term archival storage. Once dissolved, solutions are typically kept cold and protected from light, since aqueous peptide solutions can lose integrity through hydrolysis or oxidation over time. Stability data specific to this fragment are limited in the public literature, and much of the guidance comes from general peptide handling practice rather than from controlled degradation studies. Users therefore treat stated shelf lives as approximate rather than fixed.
Identity and purity are normally assessed with reversed-phase high-performance liquid chromatography, paired with mass spectrometry to confirm molecular mass. A certificate of analysis reports a purity percentage, usually derived from chromatographic peak area, but that figure does not by itself prove a correct sequence or the absence of counterions. Independent verification may include amino acid analysis or peptide mapping. Batch-to-batch variation is a documented concern in the research chemical market, and the gap between a quoted purity value and actual peptide content can be substantial when the material is a salt or retains residual water.
Kinohimitsu (木の秘密, Kinohimitsu) is a functional beauty and health brand owned by Kino Biotech, a leading integrated bio-nutraceutical and cosmeceutical public listed company in the Taiwan's GreTai Securities Market (GTSM) with its head office in Singapore. According to Euromonitor International, Kinohimitsu was the top selling beauty drink and collagen drink in Malaysia and Singapore between 2008 and 2010. The brand name, (木の秘密) means the secret of Nature.
=== Luton Town === Having been released from Everton in June 2023, Townsend spent preseason on trial with newly promoted Premier League side Burnley as a free agent ahead of the 2023–24 season. It was reported that contractual agreements had initially been made with Burnley, but these were later cancelled prior to the start of the season, leaving Townsend without a club. He later described the collapsed move as "the toughest conversation I've had in my career" and that he was "in tears" when he was informed. Following the failed move to Burnley, Townsend began a trial with Luton Town, whom also were newly promoted to the Premier League. On 11 October 2023, he officially signed for the club on a short-term contract until January 2024. He made his debut for the club as a substitute in an away league match at Nottingham Forest on 21 October. On 23 December, Townsend scored his first goal for the Hatters in a 1–0 win over his former club Newcastle United at Kenilworth Road. In January 2024, Townsend signed a new long-term contract with Luton Town.
== Common biopolymers == Collagen: Collagen is the primary structure of vertebrates and is the most abundant protein in mammals. Because of this, collagen is one of the most easily attainable biopolymers, and used for many research purposes. Because of its mechanical structure, collagen has high tensile strength and is a non-toxic, easily absorbable, biodegradable, and biocompatible material. Therefore, it has been used for many medical applications such as in treatment for tissue infection, drug delivery systems, and gene therapy. Silk fibroin: Silk Fibroin (SF) is another protein rich biopolymer that can be obtained from different silkworm species, such as the mulberry worm Bombyx mori. In contrast to collagen, SF has a lower tensile strength but has strong adhesive properties due to its insoluble and fibrous protein composition. In recent studies, silk fibroin has been found to possess anticoagulation properties and platelet adhesion. Silk fibroin has been additionally found to support stem cell proliferation in vitro. Gelatin: Gelatin is obtained from type I collagen consisting of cysteine, and produced by the partial hydrolysis of collagen from bones, tissues and skin of animals. There are two types of gelatin, Type A and Type B. Type A collagen is derived by acid hydrolysis of collagen and has 18.5% nitrogen. Type B is derived by alkaline hydrolysis containing 18% nitrogen and no amide groups. Elevated temperatures cause the gelatin to melts and exists as coils, whereas lower temperatures result in coil to helix transformation.
=== Dysregulated immune response === Another area of interest is the immune system's ability to distinguish between self and non-self, a function that is compromised in autoimmune diseases. In healthy individuals, immune tolerance prevents the immune system from attacking the body's own cells. When this process fails, the immune system may produce antibodies against its own tissues, leading to an autoimmune response.
Sources: en.wikipedia.org
It is descriptive rather than prescriptive. Bias and unfairness may go undetected because the developers are overwhelmingly white and male: among AI engineers, about 4% are black and 20% are women. There are various conflicting definitions and mathematical models of fairness. These notions depend on ethical assumptions, and are influenced by beliefs about society. One broad category is distributive fairness, which focuses on the outcomes, often identifying groups and seeking to compensate for statistical disparities. Representational fairness tries to ensure that AI systems do not reinforce negative stereotypes or render certain groups invisible. Procedural fairness focuses on the decision process rather than the outcome. The most relevant notions of fairness may depend on the context, notably the type of AI application and the stakeholders. The subjectivity in the notions of bias and fairness makes it difficult for companies to operationalise them. Having access to sensitive attributes such as race or gender is also considered by many AI ethicists to be necessary in order to compensate for biases, but it may conflict with anti-discrimination laws. At the 2022 ACM Conference on Fairness, Accountability, and Transparency a paper reported that a CLIP‑based (Contrastive Language-Image Pre-training) robotic system reproduced harmful gender‑ and race‑linked stereotypes in a simulated manipulation task.
On 5 May, a national uprising began spontaneously in Prague, and the newly formed Czech National Council (cs) almost immediately assumed leadership of the revolt. Over 1,600 barricades were erected throughout the city, and some 30,000 Czech men and women battled for three days against 40,000 German troops backed by tanks, aircraft and artillery. On 8 May, the German Wehrmacht capitulated; Soviet troops arrived on 9 May.
=== Connection with Cancer treatment === hCTR1 is upregulated in various cancer types, and it's associated with prognosis in several solid tumors. Atox1 and ATP7B were found to be important for Pt-based drug resistance. hCTR1 plays a role in oncology, hCTR1 facilitates uptake of platinum-based chemotherapeutic agents, such as cisplatin. Yeast and mammalian cells lacking CTR1 were resistant to cisplatin, while cells overexpressing CTR1 accumulated more of the drug. Tumor cells when exposed to cisplatin often react by increased degradation of hCTR1, thereby they become drug-resistant while simultaneously exhibiting signs of perturbed copper homeostasis. Studies of Atox1 in cancer cells demonstrated that this copper chaperone is crucial for cancer cell proliferation and survival. Small molecules targeting Atox1 have been proved to effectively block Cu-trafficking. For that reason reduce cell proliferation in lung, leukemia, breast, head, and neck cancer cell lines by elevating cellular ROS levels and reducing cellular NADPH and GSH levels. In contrast, healthy cells were barely affected by these small molecules.
Sources: en.wikipedia.org
No. Thymosin beta-4 is a 43-residue protein, while TB-500 refers to a seven-residue fragment corresponding to its N-terminal region. The two names are often used loosely in commercial and community writing, which obscures the difference in size, sequence, and likely behavior.
The fragment contains an actin-binding motif, and cell-free experiments show that it can interact with monomeric actin. That observation is the basis for interest in cell migration and repair processes. Effects reported in animals are not established for humans.
Purity is usually stated by the supplier rather than fixed by a pharmacopoeial monograph, and typical listings report a percentage from reverse-phase HPLC. Independent verification is uncommon. Because no single accepted specification exists, comparisons between lots and between suppliers are difficult.
The leading proposal involves sequestration of monomeric actin, which would alter cytoskeletal turnover and cell movement. The actin-binding motif shared with the parent protein is central to that idea. Direct confirmation in whole organisms remains limited.